WO2001070684A3 - Peptidomimetic ligands for cellular receptors and ion channels - Google Patents

Peptidomimetic ligands for cellular receptors and ion channels Download PDF

Info

Publication number
WO2001070684A3
WO2001070684A3 PCT/US2001/006173 US0106173W WO0170684A3 WO 2001070684 A3 WO2001070684 A3 WO 2001070684A3 US 0106173 W US0106173 W US 0106173W WO 0170684 A3 WO0170684 A3 WO 0170684A3
Authority
WO
WIPO (PCT)
Prior art keywords
ion channels
present
compounds
receptors
cellular receptors
Prior art date
Application number
PCT/US2001/006173
Other languages
French (fr)
Other versions
WO2001070684A2 (en
Inventor
Paul E Persons
Joanne M Holland
James R Hauske
Original Assignee
Sepracor Inc
Paul E Persons
Joanne M Holland
James R Hauske
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc, Paul E Persons, Joanne M Holland, James R Hauske filed Critical Sepracor Inc
Priority to AU2001239896A priority Critical patent/AU2001239896A1/en
Priority to US10/203,279 priority patent/US7115664B2/en
Publication of WO2001070684A2 publication Critical patent/WO2001070684A2/en
Publication of WO2001070684A3 publication Critical patent/WO2001070684A3/en
Priority to US11/512,056 priority patent/US7446115B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Abstract

One aspect of the present invention relates to novel peptidomimetic compounds. A second aspect of the present invention relates to the use of the novel peptidomimetic compounds as ligands - agonists or antagonists - for various cellular receptors, e.g., G-protein-coupled receptors and opioid receptors, and various cellular ion channels, e.g., sodium and calcium. In certain embodiments, compounds of the present invention preferentially or selectively inhibit sodium or calcium ion channels. In certain embodiments, compounds of the present invention preferentially or selectively agonize or antagonize ν-opioid receptors. In certain embodiments, compounds of the present invention preferentially or selectively inhibit sodium or calcium ion channels and agonize or antagonize ν-opioid receptors.
PCT/US2001/006173 2000-03-16 2001-02-27 Peptidomimetic ligands for cellular receptors and ion channels WO2001070684A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001239896A AU2001239896A1 (en) 2000-03-16 2001-02-27 Peptidomimetic ligands for cellular receptors and ion channels
US10/203,279 US7115664B2 (en) 2000-03-16 2001-02-27 Peptidomimetic ligands for cellular receptors and ion channels
US11/512,056 US7446115B2 (en) 2000-03-16 2006-08-29 Peptidomimetic ligands for cellular receptors and ion channels

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19013300P 2000-03-16 2000-03-16
US60/190,133 2000-03-16

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10203279 A-371-Of-International 2001-02-27
US11/512,056 Continuation US7446115B2 (en) 2000-03-16 2006-08-29 Peptidomimetic ligands for cellular receptors and ion channels

Publications (2)

Publication Number Publication Date
WO2001070684A2 WO2001070684A2 (en) 2001-09-27
WO2001070684A3 true WO2001070684A3 (en) 2002-03-07

Family

ID=22700136

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/006173 WO2001070684A2 (en) 2000-03-16 2001-02-27 Peptidomimetic ligands for cellular receptors and ion channels

Country Status (3)

Country Link
US (2) US7115664B2 (en)
AU (1) AU2001239896A1 (en)
WO (1) WO2001070684A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405234B2 (en) 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
EP1567487A4 (en) * 2002-11-15 2005-11-16 Bristol Myers Squibb Co Open chain prolyl urea-related modulators of androgen receptor function
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US7820702B2 (en) 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
US7625923B2 (en) 2004-03-04 2009-12-01 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
WO2006055951A2 (en) * 2004-11-19 2006-05-26 Portola Pharmaceuticals, Inc. Tetrahydroisoquinolines as factor xa inhibitors
US20120136416A1 (en) * 2010-11-19 2012-05-31 President And Fellows Of Harvard College Caged Neuropeptides: modulation and measurement of synapse and signaling activity; and methods for drug evaluation, pharmaceuticals preparation and treatment

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364850A (en) * 1992-05-20 1994-11-15 G. D. Searle & Co. Substituted tyrosyl diamide compounds
WO1996040208A1 (en) * 1995-06-07 1996-12-19 Torrey Pines Institute For Molecular Studies Novel mu opioid receptor ligands: agonists and antagonists
WO1998049141A1 (en) * 1997-04-30 1998-11-05 Warner-Lambert Company Kappa opioid agonists
WO1999065932A1 (en) * 1998-06-18 1999-12-23 Sepracor, Inc. Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors
WO1999067206A1 (en) * 1998-06-22 1999-12-29 Astrazeneca Ab Novel compounds useful in pain management
WO2001010439A1 (en) * 1999-08-04 2001-02-15 Teijin Limited Cyclic amine ccr3 antagonists

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3626130A1 (en) 1986-08-01 1988-02-11 Merck Patent Gmbh AMINO ACID DERIVATIVES
US5750646A (en) 1987-09-24 1998-05-12 The Administrators Of The Tulane Educational Fund Bradykinin analogs with non-peptide bond
US5430022A (en) 1990-05-14 1995-07-04 Fujisawa Pharmaceutical Co., Ltd. Peptide compound and its preparation
US5284828A (en) 1990-05-14 1994-02-08 Fujisawa Pharmaceutical Co. Ltd. Peptide compound and its preparation
US5496928A (en) * 1990-06-07 1996-03-05 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic substance
GB9123967D0 (en) 1991-11-12 1992-01-02 Fujisawa Pharmaceutical Co New compound and its preparation
TW217417B (en) * 1991-12-04 1993-12-11 Manyu Seiyaku Kk
US5574159A (en) 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5681830A (en) 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
US5807858A (en) 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
FR2687147A1 (en) * 1992-02-11 1993-08-13 Union Pharma Scient Appl NOVEL ALPHA-AMINO N-PYRIDYL BENZENE PROPANAMIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
EP0711289B1 (en) 1993-07-30 2000-08-23 Delta Pharmaceuticals, Inc. Piperazine compounds used in therapy
IS4261A (en) 1994-02-21 1995-08-22 Astra Aktiebolag New peptide opioids for the treatment of pain and their use
JP3286925B2 (en) * 1994-06-30 2002-05-27 富士通株式会社 Mobile device and dial lock setting method for the mobile device
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5646151A (en) 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5688955A (en) 1996-03-08 1997-11-18 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
US5760023A (en) 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364850A (en) * 1992-05-20 1994-11-15 G. D. Searle & Co. Substituted tyrosyl diamide compounds
WO1996040208A1 (en) * 1995-06-07 1996-12-19 Torrey Pines Institute For Molecular Studies Novel mu opioid receptor ligands: agonists and antagonists
WO1998049141A1 (en) * 1997-04-30 1998-11-05 Warner-Lambert Company Kappa opioid agonists
WO1999065932A1 (en) * 1998-06-18 1999-12-23 Sepracor, Inc. Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors
WO1999067206A1 (en) * 1998-06-22 1999-12-29 Astrazeneca Ab Novel compounds useful in pain management
WO2001010439A1 (en) * 1999-08-04 2001-02-15 Teijin Limited Cyclic amine ccr3 antagonists

Non-Patent Citations (34)

* Cited by examiner, † Cited by third party
Title
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173022, retrieved from STN Database accession no. 2001:789895 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173023, retrieved from STN Database accession no. 2001:789894 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173024, retrieved from STN Database accession no. 2001:789893 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173025, retrieved from STN Database accession no. 2001:789892 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173026, retrieved from STN Database accession no. 2001:789891 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173027, retrieved from STN Database accession no. 2001:789890 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173028, retrieved from STN Database accession no. 2001:789889 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173029, retrieved from STN Database accession no. 2001:789888 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173030, retrieved from STN Database accession no. 2001:789887 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173031, retrieved from STN Database accession no. 2001:789886 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173032, retrieved from STN Database accession no. 2001:789885 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173033, retrieved from STN Database accession no. 2001:789884 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173034, retrieved from STN Database accession no. 2001:789883 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173035, retrieved from STN Database accession no. 2001:789882 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173036, retrieved from STN Database accession no. 2001:789881 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173037, retrieved from STN Database accession no. 2001:31780 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173038, retrieved from STN Database accession no. 2001:31779 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173039, retrieved from STN Database accession no. 2001:31778 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173040, retrieved from STN Database accession no. 2001:31777 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173041, retrieved from STN Database accession no. 2001:31776 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173042, retrieved from STN Database accession no. 2001:31775 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173043, retrieved from STN Database accession no. 2001:31774 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173044, retrieved from STN Database accession no. 2001:31773 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173045, retrieved from STN Database accession no. 2000:860620 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173046, retrieved from STN Database accession no. 2000:860619 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173047, retrieved from STN Database accession no. 2000:860618 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173048, retrieved from STN Database accession no. 2000:860617 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173049, retrieved from STN Database accession no. 2000:860616 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173050, retrieved from STN Database accession no. 2000:859547 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173051, retrieved from STN Database accession no. 2000:859546 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173052, retrieved from STN Database accession no. 2000:856648 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173053, retrieved from STN Database accession no. 2000:856590 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173054, retrieved from STN Database accession no. 2000:856589 *
DATABASE CHEMCATS [online] 16 September 1999 (1999-09-16), XP002173055, retrieved from STN Database accession no. 2000:856588 *

Also Published As

Publication number Publication date
US7115664B2 (en) 2006-10-03
US7446115B2 (en) 2008-11-04
AU2001239896A1 (en) 2001-10-03
US20050080271A1 (en) 2005-04-14
WO2001070684A2 (en) 2001-09-27
US20070093522A1 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
AU2003256619A1 (en) Pyrrolopyrimidine thionucleoside analogs as antivirals
MXPA03002297A (en) Triazole compounds useful as protein kinase inhibitors.
WO2000071518A3 (en) Heterocyclic analgesic compounds and their use
MX255195B (en) Fungicidal mixture containing arylamidine derivatives.
MXPA03005610A (en) Pyrazole compounds useful as protein kinase inhibitors.
HUP0303547A3 (en) Elastomeric composition
AU2002220265A1 (en) Compositions for inhibiting grb7
IL155702A0 (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5-ht2 receptor
HK1071572A1 (en) PyrazoloÄ1,5-AÜpyrimidine compounds as cyclin dependent kinase inhibitors
YU39803A (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2-receptor
PL358057A1 (en) Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
HUP0303578A3 (en) Elastomeric composition
AU7901101A (en) Compounds having mif antagonist activity
WO2002069895A3 (en) Heterocyclic analgesic compounds and methods of use thereof
WO2001068604A3 (en) 3-substituted piperidines comprising urea functionality, and methods of use thereof
WO2001070684A3 (en) Peptidomimetic ligands for cellular receptors and ion channels
AU2002358067A1 (en) Nitrogen-containing compounds as corrosion inhibitors
AU2001266486A1 (en) New compounds useful as antibacterial agents
AU2001282574A1 (en) Reagent for determining singlet oxygen
EP1262195A4 (en) Vasoactive agents
SI1261588T1 (en) IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS
WO2003072811A3 (en) The use of ribozymes in the detection of adventitious agents
FR2822882B3 (en) WATERPROOF TYPE JOINERY, PARTICULARLY FOR CIVIL USE
WO2002083071A3 (en) Heterocyclic analgesic compounds and methods of use thereof
WO2003034027A3 (en) Whole cell assay

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10203279

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP